Citadel Group Ltd (ASX: CGL) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Citadel Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Citadel Group Ltd (ASX: CGL)
Latest News

share price crash
Share Fallers

Why Citadel, Coles, Nearmap, & WiseTech Global are tumbling lower

Coles Group Ltd (ASX:COL) and WiseTech Global Ltd (ASX:WTC) shares are two of four tumbling notably lower on Wednesday. Here's why...

Read more »

M&A Letters merger acquisition divestment spin-off ASX shares to buy
Share Market News

Citadel announces half year results and $200 million healthcare acquisition

The Citadel Group Ltd (ASX:CGL) share price is in a trading halt after the release of its half year results…

Read more »

a woman
Share Market News

ALL ORDINARIES finishes lower Monday: 8 ASX shares you missed

The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) ended down on Monday, here are 8 ASX shares you missed.

Read more »

asx shares higher
Share Gainers

Why the Citadel share price is racing higher on Monday

The Citadel Group Ltd (ASX:CGL) share price has been a strong performer on the All Ordinaries on Monday. Here's why…

Read more »

ASX shares higher
Share Market News

Why Citadel, Evolution, PolyNovo, & Pro Medicus shares are charging higher

The Evolution Mining Ltd (ASX:EVN) share price and the PolyNovo Ltd (ASX:PNV) share price are two of four charging higher…

Read more »

share price higher
Technology Shares

2 ASX tech shares that could fly in 2020

Here's why I think Citadel Group Ltd (ASX: CGL) and Tinybeans Group Ltd (ASX: TNY) are 2 ASX tech shares…

Read more »

best asx shares represented by best in show ribbon
⏸️ Investing

What top ASX shares are analysts eyeing up for 2020?

Analysts from Bell Potter recently released a report detailing their outlook and top ASX stock picks for 2020. Here's a…

Read more »

Health technology shares
Share Gainers

Here’s why the Citadel share price rose almost 4%

The Citadel Group Ltd (ASX:CGL) share price rose by nearly 4% after giving investors an update regarding a health contract. 

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
07 Dec 2020 $0.2000 100.00% Special Cash 17 Dec 2020
02 Sep 2020 $0.0600 100.00% Final 01 Oct 2020
25 Feb 2020 $0.0480 100.00% Interim 27 Mar 2020
23 Aug 2019 $0.0600 100.00% Final 27 Sep 2019
22 Feb 2019 $0.0480 100.00% Interim 29 Mar 2019
23 Aug 2018 $0.0900 100.00% Final 28 Sep 2018
22 Feb 2018 $0.0480 100.00% Interim 29 Mar 2018
24 Aug 2017 $0.0800 100.00% Final 29 Sep 2017
23 Feb 2017 $0.0480 100.00% Interim 31 Mar 2017
25 Aug 2016 $0.0480 100.00% Final 30 Sep 2016
24 Feb 2016 $0.0480 100.00% Interim 31 Mar 2016
27 Aug 2015 $0.0580 100.00% 30 Sep 2015

CGL ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Citadel Group Ltd

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Ms Jayne Andrea Shaw Non-Executive Director Jun 2020
Ms Shaw brings to the Board not only her experience in healthcare management, but also an experienced clinical background in nursing. Jayne has acted in senior management roles in two Australian private hospitals and established an Australian and international consulting business which was sold to Healthsouth, a large US Healthcare company. After this, Jayne became the co-founder of Vision Group, a business that was successfully listed on the ASX.
Jayne has been a member of a number of private healthcare boards involved with specialist consolidation including cardiology, cancer care, orthopaedics, and women's health and has continued to work with private equity firms on local and international healthcare transactions.
Jayne also holds positions on the boards of Mable Technologies, the Woolcock Research Institute, and The Hareda Foundation, and as Chairman of BCAL Diagnostics. She is also Member of Risk and Compliance Committee.
Mr Lt-Gen Peter Francis Leahy Non-Executive DirectorNon-Executive Chairman Jun 2014
Lt-Gen Leahy retired from the Australian Army in July 2008, after a 37-year career. He retired as a Lieutenant General in the position of Chief of Army, a position he held for 6 years. In this appointment he was directly accountable for Army's $6 billion annual budget and his responsibilities included the detailed management of personnel, operating and capital cost centres and the direct responsibility to raise, train and sustain the Army. He was the principal adviser to the Chief of the Defence Force on strategic matters related to the deployment of the Army on global combat operations. He is now a Professor and Foundation Director of the National Security Institute at the University of Canberra.
He is a technical adviser to the board of WarpForge Limited.
In work related to charities he is the Chairman of Soldier On, Salvation Army Red Shield Appeal Committee in the ACT and the Australian Student Veterans Association.
Lt Gen Peter Leahy's qualifications include UNSW, USACGS and Fellow, Australian Centre for Defence and Strategic Studies. He is also Member of Risk and Compliance Committee.
Mr Mark Steven McConnell Chief Executive OfficerManaging Director Jul 2016
Mr McConnell is a business developer whose skills cover areas of business strategy, investor relations, capital raising and innovation. After serving as an officer in the Royal Australian Air Force for 8 years, Mark moved into the corporate world in 1997 and has worked across various executive roles in the fields of aviation, technology and investment banking. In 2007, he founded and ran New Territories Investments, a private equity fund that has assisted the growth strategies of multiple technology businesses in Australia, including Citadel.
Mark was awarded the ACT Young Entrepreneur of the Year in 2003 and 2006.
He is also director and deputy Chair of Cricket ACT (Inc), a board adviser to HOF Capital and a committee member of the Red Shield Appeal.
Mr Robert Ian Alexander Non-Executive Director Dec 2019
Mr Alexander is an experienced senior executive and director with over 30 years experience working in the commercial sector, primarily in sectors undergoing significant digital and technology transformation. Bob has worked in global organisations in industries such as media, entertainment, professional services, intellectual property and the print industry. He has considerable experience in corporate governance, mergers and acquisitions, and has led numerous transactions and the integration of acquired businesses. Bob is an Executive board and committee member of the Cambodian Children's Fund (Hong Kong) and Cambodian Children's Fund Australia Inc. He sits on the advisory board of, a digital platform connecting authors and readers. Bob is a leader in corporate social responsibility and is an Executive Board Member of the Cambodian Children's Fund, overseeing global strategy, organisational development, IT infrastructure and systems with global responsibility for fundraising and operations. He was previously a Non-executive Director of QMS Media Ltd and a Non-executive Director and Chairman of the Audit and Risk Committee of Xenith IP Group Ltd. He is also Chair of Risk and Compliance Committee.
Mrs Jennifer(Jenny) Martin Chief Financial OfficerJoint Company Secretary Aug 2018
Mr Spencer Chipperfield Company Secretary Mar 2019
Jennifer(Jenny) Martin Chief Financial OfficerJoint Company Secretary
Spencer Chipperfield Company Secretary

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
J P Morgan Nominees Australia Pty Limited 7,911,321 10.05%
Hsbc Custody Nominees (Australia) Limited 7,253,382 9.22%
National Nominees Limited 6,817,636 8.66%
Bryony McConnell 6,265,530 7.96%
Citicorp Nominees Pty Limited 5,952,365 7.56%
Equitas Nominees Pty Limited 5,476,181 6.96%
Bnp Paribas Nominees Pty Ltd 2,943,387 3.74%
PJA Australia Pty Ltd 2,753,095 3.50%
Ubs Nominees Pty Ltd 1,355,435 1.72%
Capital Property Corporation Pty Ltd 1,246,521 1.58%
Brispot Nominees Pty Ltd 1,230,125 1.56%
Cs Fourth Nominees Pty Limited 1,090,459 1.39%
HSBC Custody Nominees (Australia) Limited A/C 2 984,489 1.25%
Christopher Paul Yeowart 938,792 1.19%
Bnp Paribas Noms Pty Ltd 833,835 1.06%
Jakeman Holding Co Pty Ltd 800,000 1.02%
Graham Paul Ridgway 732,009 0.93%
Citicorp Nominees Pty Limited i 689,000 0.88%
National Nominees Limited i 639,052 0.81%
Abbysah Pty Limited 500,000 0.64%